When the causal mutation is known, the challenge shifts from identifying disease origins to defining its detectable beginning. For decades, the study of Alzheimer’s disease has been framed by a ...
Background Autosomal dominant Alzheimer’s disease (ADAD) serves as a model for presymptomatic biomarker discovery. Characterising the temporal profile of plasma biomarker levels in presymptomatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results